The unmissable event for innovation and transformation in the French Grand Est region. The 360 Grand Est returns on 22 and 23 June 2023 at the Palais de la Musique et des Congrès in Strasbourg and online for its 4th edition: "Let’s shape the future, here". 💡 360 Grand Est is the unmissable event for innovation and transformation in the French Grand Est region. Conferences, workshops, masterclasses, round tables, pitches, demonstrations, exhibitor meetings, Job Open Day, business convention... Get ready to enter a rich and inspiring program...Together, let's accelerate our transformations and attract talent! WHY 360❓ All the active forces …

Sectors: Trade show

[Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from fundamental research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Care The Institut Curie Hospital Group is a reference center for breast cancer, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians and doctors are mobilizing …

Sectors: Health

[Automatic translation follows] The DGE designs and implements policies in favor of competitiveness and business growth. The Directorate General for Enterprises serves the Minister of Economy and Finance. Our action is at the heart of the Government's projects in favor of the economic transformation and strategic autonomy of the country. In the service of business competitiveness, it carries out industrial policy, defines digital regulatory measures, as well as policies to support the local economy. It supports businesses in the digital and ecological transformation of the economy, and works in favor of regulatory simplification and an ambitious innovation policy. Its missions …

Sectors: National and local authorities

La recherche publique a mille talents. Profitez-en pour innover ! Welcome :) #tech #deeptech #innovation #eastoffrance Trait d’union entre la recherche publique alsacienne et les entreprises, la SATT Conectus conduit les inventions qui naissent au cœur des laboratoires jusqu’au marché. Elle protège leurs découvertes, finance et accompagne les projets prometteurs jusqu’à leur adoption par les industriels et/ou investisseur, en portant le risque technologique et financier. Conectus est également opérateur pour le compte de la majorité de ses actionnaires de la mise en œuvre des partenariats Chercheurs / Entreprises. ----------- SATT* Conectus Alsace is the main entry point for business partners …

Tags: SATT Network Sectors: Research

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale …

Sectors: Pharmaceutical

[Automatic translation follows] Incubator of excellence of the Grand Est Region, member of the Quest for change network Created in 1999, SEMIA is an incubator of excellence of the Grand Est Region, certified by the Ministry of Higher Education and Research. SEMIA is open to all innovative project leaders regardless of their field of activity. Our method offers tailor-made support depending on the maturity of the projects. This support is done in two phases: - a collective incubation through Starter Classes given by experts - an individual incubation with a business manager dedicated to the project SEMIA is a member …

Sectors: Startup accelerator & VC

[Automatic translation follows] Dynamic, competitive and innovative, the Grand Est Region is at your side and at your service. Priorities → #Employment #Digital #Youth #Territories #Mobility #Europe Find us on https://www.grandest.fr/ Also follow the news on our social networks: - Twitter: @regiongrandest - Facebook: @regiongrandest - Instagram: @laregiongrandest local authority

Sectors: National and local authorities

Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment …

Sectors: Biotechnology French Cluster Public business cluster

Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and …

Sectors: French Cluster Public business cluster

[Automatic translation follows] Cooperative banks, the Caisses d'Epargne have been combining trust, solidarity and modernity since 1818. The second largest banking network in France, the 16 regional Caisses d'Epargne are among the leading banks in their region. They support all economic players and are leaders in financing the public sector, social housing and the social economy. In total, the Caisses d'Epargne now have 4.8 million members and 20.6 million customers, managed by the 4,182 bank branches and the Mon banquier en ligne agency.

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines

Sectors: Pharmaceutical

Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: …

Sectors: Biotechnology Startup accelerator & VC

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, …

Sectors: Biotechnology Pharmaceutical

Aiming to promote nuclear disarmament and non-proliferation and the strengthening of the disarmament regimes. The Office for Disarmament Affairs supports multilateral efforts aimed at achieving the ultimate goal of general and complete disarmament under strict and effective international control.

Sectors: International development

We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them.

Sectors: Pharmaceutical

Driving change to defeat serious chronic diseases, built upon our heritage in diabetes. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments …

Sectors: Pharmaceutical

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy

Sectors: Pharmaceutical

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business

Sectors: Pharmaceutical

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care

Sectors: Pharmaceutical

Notre cabinet d’avocats dispose d’une grande expertise dans de nombreux secteurs d’activité dans plus de 45 pays. CMS Francis Lefebvre Avocats is one of the leading international corporate law firms. It is ranked 2nd largest law firm in France by revenue. Its deep roots, unique positioning and highly recognised expertise enable it to deliver innovative, high-value-added solutions in Tax, Business, Corporate and Employment law. CMS Francis Lefebvre Avocats is a member of CMS. Founded in 1999, CMS, with more than 74 offices in 42 countries across the world, is the 3rd international law firm. Employing over 4,500 lawyers, CMS has …

Sectors: Law Practice

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, …

Tags: DAX30 Sectors: Biotechnology Pharmaceutical

[Automatic translation follows] Together, let's make France grow! The Caisse des dépôts et consignations is a long-term investor and contributes, while respecting its patrimonial interests, to the development of companies. Article L. 518-2 of the Monetary and Financial Code (amended by the 2008 law on the modernization of the economy) Support for public policies, Investment, Pensions and Savings Funds, and Territorial Development

Sectors: Finance

[Automatic translation follows] The 1st business accelerator The CCI Alsace Eurométropole is a public institution managed by 30 volunteer business leaders elected for 5 years. It represents the 90,000 companies in industry, commerce and services in Alsace. It actively participates in the development of the local economy. Our actions are structured around major missions: - Represent the interests of companies. - Support business creators and buyers. - Mobilize our expertise and our networking capacity to support our companies' projects throughout their life. - Deploy an initial, continuing or apprenticeship training offer, in particular thanks to our CCI Campus training center. …

Sectors: Chamber of commerce

[Automatic translation follows] The National Agency for Territorial Cohesion (ANCT) supports local authorities in the development of their territorial projects. Created on January 1, 2020, it brings together the General Commission for Territorial Equality, the Digital Agency and Epareca. Support for local authorities, Advice to local authorities, Project facilitator, Financial engineering, Technical engineering, Assistance to public project management, Project engineering, and Steering of national support programs

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth. With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we …

Sectors: Biotechnology

At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. ​ All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. ​ Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals

Sectors: Pharmaceutical

[Automatic translation follows] Within the Ministry, more than 135,000 agents today put their talent to work for a strong and sustainable economy in the region and in Paris. User services, legal affairs, economic development, performance management... more than 160 professions are practiced in the Bercy administrations. The diversity of these sectors of activity makes it possible to build rich career paths adapted to each person's profile. How to join the Bercy services? Each year, the ministry recruits 5,000 women and men. Numerous competitions at all levels are organized. Recruitment procedures without competition also exist, for disabled workers and young people …

[Automatic translation follows] The priorities of the Ministry of National Education, Higher Education and Research are: - to improve student success and promote equal opportunities; - to coordinate the training offer of French higher education; - to set priority areas for the progress of knowledge and technologies; - as well as the public research and innovation strategy. In this context, the so-called "ESR" law of July 22, 2013 also advocates transformation and openness to all forms of teaching and research, to the socio-economic environment, and to the international. Among the key measures put in place: - The definition of a …

Our people are our strength. And, together with over 53,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing

Sectors: Animal Health Pharmaceutical

Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our …

Sectors: Pharmaceutical

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, …

Sectors: Pharmaceutical